Metabolomics key to identifying disease pathway: Research reveals lactic acid's role in lung disease

January 14, 2013, Pacific Northwest National Laboratory
Top: Lactic acid concentrations were measured in whole lung homogenates using ¹H-PASS nuclear magnetic resonance (NMR) spectroscopy obtained from patients with idiopathic pulmonary fibrosis (IPF) and compared with healthy control subjects. Bottom: Lactate dehydrogenase-5 (LDH5) expression is elevated in fibroblasts and lung tissue from IPF patients. LDH5 is responsible for the generation of lactic acid. Immunohistochemistry is shown for LDH5 performed on lung tissue sections from a healthy control subject (left) and a patient with IPF (right). LDH5 expression, shown as the reddish-brown stained area, is increased in the lung tissue of patients with IPF.

(Medical Xpress)—Expertise at Pacific Northwest National Laboratory contributed to the understanding of the role of cellular metabolism in the pathogenesis of a currently untreatable lung disease. This research, reported in the American Journal of Respiratory and Critical Care Medicine, highlights the importance of PNNL's nuclear magnetic resonance (NMR) metabolomics in the field of biomedicine.

"This work was, in fact, stimulated by the findings from our metabolic profiling studies," said Dr. Jianzhi Hu, a PNNL NMR expert and physicist who, with NMR spectroscopist and biochemist Nancy Isern, provided the study's NMR data. The work was led by University of Rochester researchers Drs. Patricia Sime (MD), R. Matthew Kottmann (MD), and Richard Phipps (PhD) and included researchers from Inova Fairfax Hospital Heart & Vascular Institute and George Mason University.

Scientists increasingly recognize that dysregulated, or impaired, impacts disease processes. However, they know little about the role of cellular metabolism as it relates to lung disease. Greater understanding of the dysregulated processes in human diseases will help in developing improved diagnostic and treatment strategies.

The researchers investigated how the metabolite lactic acid contributes to pulmonary fibrosis, or scarring of the lung. They identified increased levels of lactic acid and increased expression of the enzyme responsible for the production of lactic acid, lactate dehydrogenase (LDH), in the lung tissues of patients with idiopathic—from an unknown cause—pulmonary fibrosis (IPF) compared to healthy controls. Lactic acid, which is typically produced via LDH during vigorous exercise or other anaerobic conditions such as hypoxia, was also elevated in scar-forming cells in the lung called myofibroblasts.

The team further demonstrated that the concentrations of lactic acid present in the diseased lung tissue activated an important fibrosis-promoting molecule, transforming growth factor beta (TGF-b). Furthermore, TGF-b was shown to increase the expression of LDH, thereby potentially contributing to a pro-fibrotic feed-forward loop. More important, the team also demonstrated that inhibition of LDH significantly reduced the fibrosis-promoting effects of TGF-b, thus identifying LDH as a novel potential target for therapy for patients with IPF.

These data support the role of lactic acid and LDH5 in the initiation and/or progression of pulmonary fibrosis. While the concept of lactic acid elevation in tissue with restricted blood flow is not new, the concept that the elevated concentrations are playing a key physiologic role in a lung disease represents a broader understanding of lung physiology. This work also highlights the importance of combining metabolomics studies with translational and clinical research.

This study provides an exciting first step for a novel, direct measurement of metabolites and their associated metabolic pathways that are dysregulated in human lung disease. Many more metabolites have been identified as being either increased or decreased in IPF compared to healthy controls. Interrogation of their associated metabolic pathways is ongoing. This investigation is expected to help identify additional novel treatment targets for patients with IPF. In addition, the researchers are expanding their analyses to include other lung diseases, such as chronic obstructive (COPD), sarcoidosis, and other idiopathic lung disorders.

Explore further: Progression of lung fibrosis blocked in mouse model

More information: Kottman, R. 2012. Lactic Acid is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation Via pH-Dependent Activation of Transforming Growth Factor-β. American Journal of Respiratory and Critical Care Medicine 186(8):740-751. DOI: 10.1164/rccm.201201-0084OC

Related Stories

Progression of lung fibrosis blocked in mouse model

October 5, 2011
A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy ...

Common genetic variant linked to pulmonary fibrosis risk

April 20, 2011
Scientists funded by the National Institutes of Health have identified a common genetic variant associated with substantially increased risk of developing pulmonary fibrosis, a debilitating and life-threatening lung condition. ...

New insights come from tracing cells that irreversibly scar lungs

December 1, 2011
Idiopathic Pulmonary Fibrosis (IPF) is an incurable disease in which the delicate gas exchange region of the lung fills with scar tissue, which interferes with breathing. Now researchers at Duke University Medical Center ...

Recommended for you

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.